Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Suaya, Jose A ^a   Mera, Robertino M ^b   Cassidy, Adrian ^c   O'Hara, Patrick ^a   Amrine Madsen, Heather ^a   Burstin, Stuart ^a   Miller, Loren G ^d  

^a GLAXOSMITHKLINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c GSK   (Belgium)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cost; Hospitalizations; Incidence; Skin and soft tissue infections (SSTIs); Staphylococcus aureus

Indexed keywords

ADOLESCENT; ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; HEALTH CARE MANAGEMENT; HOSPITALIZATION COST; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MIDDLE AGED; OBSERVATIONAL STUDY; PATIENT CARE; RETROSPECTIVE STUDY; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES; YOUNG ADULT; ECONOMICS; FEMALE; HOSPITAL PATIENT; HOSPITALIZATION; ISOLATION AND PURIFICATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRESCHOOL CHILD; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INPATIENTS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 84902543308     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-296     Document Type: Article

References (21)

1. Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009, 15:1516-1518. 10.3201/eid1509.081228, 2819854, 19788830.
2. Itani KM, Merchant S, Lin SJ, Akhras K, Alandete JC, Hatoum HT. Outcomes and management costs in patients hospitalized for skin and skin-structure infections. Am J Infect Control 2011, 39:42-49. 10.1016/j.ajic.2010.03.018, 20673598.
3. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444. 10.1056/NEJMoa043252, 15814879.
4. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674. 10.1056/NEJMoa055356, 16914702.
5. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan EL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373-1406. 10.1086/497143, 16231249.
6. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Besser JM, O'Boyle C, Danila RN, Cheek JE, Osterholm MT, Moore KA, Smith KE. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984. 10.1001/jama.290.22.2976, 14665659.
7. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008, 168:1585-1591. 10.1001/archinte.168.14.1585, 18663172.
8. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007, 13:1840-1846. 10.3201/eid1312.070629, 2876761, 18258033.
9. Dryden M. Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: epidemiology, risk factors, and presentation. Surg Infect (Larchmt ) 2008, 9(Suppl 1):s3-10.
10. Marton JP, Jackel JL, Carson RT, Rothermel CD, Friedman M, Menzin J. Costs of skin and skin structure infections due to Staphylococcus aureus: an analysis of managed-care claims. Curr Med Res Opin 2008, 24:2821-2828. 10.1185/03007990802365169, 18759996.
11. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008, 6:751-763. 10.1586/14787210.6.5.751, 18847410.
12. Menzin J, Marton JP, Meyers JL, Carson RT, Rothermel CD, Friedman M. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus. Am J Infect Control 2010, 38:44-49. 10.1016/j.ajic.2009.04.287, 19762120.
13. Agency for Healthcare Research and Quality HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). 2001-2009 2012, http://www.hcup-us.ahrq.gov/nisoverview.jsp [serial online], Agency for Healthcare Research and Quality.
14. Certified Coding Specialist (CCS) preparation series Advance for health care professionals. Revisions address new ICD-9-CM codes, Part I 2008, http://health-information.advanceweb.com/Article/Revisions-Address-New-ICD-9-CM-Codes-Part-1.aspx [serial online], Certified Coding Specialist (CCS) preparation series.
15. United States Census Bureau National population estimates, 2001-2009 2012, http://www.census.gov/popest/data/historical/2000s/index.html, United States Census Bureau.
16. Agency for Healthcare Research and Quality HCUP Cost-to-Charge Ratio Files (CCR). Healthcare Cost and Utilization Project (HCUP). 2001-2009 2012, http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp [serial online]; Accessed September 12, 2012, Agency for Healthcare Research and Quality.
17. Bureau of Labor Statistics website Consumer price index (CPI).CPI detailed report tables 2012, http://www.bls.gov/cpi/#tables, Bureau of Labor Statistics website.
18. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011, 17:321-328. 10.1089/mdr.2010.0193, 21417776.
19. O'Hara FP, Amrine-Madsen H, Mera RM, Brown ML, Close NM, Suaya JA, Acosta CJ. Molecular Characterization of Staphylococcus aureus in the United States 2004-2008 reveals the rapid expansion of USA300 among inpatients and outpatients. Microb Drug Resist 2012, 18:555-561. 10.1089/mdr.2012.0056, 22775581.
20. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, Lessa FC, Lynfield R, Nadle J, Petit S, Ray SM, Schaffner W, Townes J, Fridkin S. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013, 173:1970-1978.
21. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008, 51:291-298. 10.1016/j.annemergmed.2007.12.004, 18222564.